Uterine leukocytes: Key players in pregnancy

Seminars in Cell and Developmental Biology

Volumn 11, Issue 2, 2000, Pages 127-137

  Hunt, Joan S ^a   Petroff, Margaret G ^a   Burnett, Tim G ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Leukocytes; Macrophages; Natural killer cells; Pregnancy; Uterus

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR; FC RECEPTOR; GROWTH FACTOR; IMMUNOGLOBULIN G; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; PEPTIDE HORMONE; PROSTAGLANDIN; SOMATOMEDIN; SOMATOMEDIN B; STEROID; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ARTICLE; AUTOCRINE EFFECT; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL MIGRATION; CHILDBIRTH; HORMONAL REGULATION; IMMUNITY; LEUKOCYTE; MACROPHAGE; MOTHER FETUS RELATIONSHIP; NATURAL KILLER CELL; NIDATION; PREGNANCY; REPRODUCTION; T LYMPHOCYTE; TRANSGENIC MOUSE; UTERUS; UTERUS BLOOD FLOW;

MUS MUSCULUS;

EID: 0034516882     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1006/scdb.2000.0158     Document Type: Article

References (83)

1. Immune cells in decidua
2. Macrophages in the uterus and placenta
3. Uterine macrophages and environmental programming for pregnancy success
4. Human uterine lymphocytes
5. Granulated lymphocytes of pregnancy
6. Role of proteases in implantation
7. CD3+CD8+CTL activity within the human female reproductive tract: Influence of stage of the menstrual cycle and menopause
8. Unique CD8+T cell-rich lymphoid aggregates in human uterine endometrium
9. Quantitative analysis of T lymphocyte subsets in pregnant and nonpregnant human endometrium
10. Evidence for the genetic control of estradiol-regulated responses. Implications for variation in normal and pathological hormone-dependent phenotypes
11. Eosinophil accumulation in rat uterus following estradiol administration is modulated by laminin and its integrin receptors
12. NKR-P1+ cells in the rat uterus: Granulated metrial gland cells are of the natural killer cell lineage
13. Localization and hormonal regulation of inducible nitric oxide synthase in cycling mouse uterus
14. Endometrial leucocytes: Expression of steroid hormone receptors
15. Physiologic regulation of postovulatory neutrophil migration into vagina in mice by a C-X-C chemokine
16. Immunoglobulins in the female genital tract
17. Mast cell regulation of human endometrial matrix metalloproteinases: A mechanism underlying menstruation
18. Synchronous expansion of intermediate TcR cells in the liver and uterus during pregnancy
19. Gamma delta T cells of human early pregnancy decidua: Evidence for local proliferation, phenotypic heterogeneity, and extrathymic differentiation
20. Immunogold labeling of perforin and serine esterases in granulated metrial gland cells
21. Synthesis and granular localization of tumor necrosis factor-alpha in activated NK cells in the pregnant mouse uterus
22. Expression of the inducible nitric oxide synthase gene in mouse uterine leukocytes and potential relationships with uterine function during pregnancy
23. The involvement of interleukin (IL)-15 in regulating the differentiation of granulated metrial gland cells in mouse pregnant uterus
24. Uterine natural killer cells are targets for a trophoblast cell-specific cytokine, prolactin-like protein-A
25. Role of cytokines in the pregnant uterus of interstitial implanting species
26. A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female fertility
27. Complexity in uterine macrophage responses to cytokines in mice
28. Cytokine production in first trimester chorionic villi: Detection of mRNAs and protein products in situ
29. Interferon-γ gene expression in cycling and pregnant mouse uterus: Temporal aspects and cellular localization
30. Time course analysis of α/β T cell clones during normal pregnancy
31. Cytokine networks in the uteroplacental unit: Macrophages as pivotal regulatory cells
32. Association of monocytes and neutrophils with early events of blastocyst implantation in mice
33. Immune reproductive failure: Effect of nonspecific immunostimulation in mouse model
34. Absence of natural killer cells during murine pregnancy is associated with reproductive compromise in TgE26 mice
35. The role of perforin-expression by granular metrial gland cells in pregnancy
36. HLA class I genes and products
37. Functions of nonclassical MHC and non-MHC-encoded class I molecules
38. The transmembrane sequence of human histocompatibility leukocyte antigen (HLA)-C as a determinant in inhibition of a subset of natural killer cells
39. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules
40. Interferon-γ contributes to the normalcy of murine pregnancy
41. Apoptosis-inducing members of the tumor necrosis factor supergene family: Potential functions in placentas
42. Trophoblastic cell lines generated from tumor necrosis factor receptor-deficient mice reveal specific functions for the two tumor necrosis factor receptors
43. Tumor necrosis factors: Pivotal factors in pregnancy?
44. Identification of transforming growth factor-β1 mRNA in virgin and pregnant rats by in situ hybridization
45. Regulatory role of γ/δ T cells in uterine intraepithelial lymphocytes in maternal antifetal immune responses
46. Tumor necrosis factor-alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation
47. Disruption of the LIF receptor
48. Uterine natural killer cells: Insights into lineage relationships and functions from studies of pregnancies in mutant and transgenic mice
49. Functional role of cell surface integrins on human trophoblast cell migration: Regulation by TGF-β IGF-II, and IGFBP-1
50. The expression of insulin-like growth factor (IGF) and IGF-binding protein genes in the human placenta and membranes: Evidence for IGF-IGFBP interactions at the feto-maternal interface
51. Paracrine actions of insulin-like growth factors and IGF binding protein-1 in non-pregnant human endometrium and at the decidualtrophoblast interface
52. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality
53. Regulation of soluble insulin-like growth factor II/mannose 6-phosphate receptor in human serum: Measurement by enzyme-linked immunosorbent assay
54. Suppression of mitogen-induced lymphoproliferation by soluble IgG Fc receptors in retroplacental serum in normal human pregnancy
55. Fcγ-receptor activity in the developing human placenta
56. The interleukin 1 receptor antagonist‰ is a partial agonist of prostaglandin synthesis by human decidual cells
57. Interleukin-1 system in the maternotrophoblast unit in human implantation: Immunohistochemical evidence for autocrine/paracrine function
58. The natural interleukin-1 receptor antagonist in the fetal, maternal, and amniotic fluid compartments: The effect of gestational age, fetal gender, and intrauterine infection
59. The interleukin-1 system in gestational tissues at term: Effect of labour
60. Regulation of prostaglandin production in intact fetal membranes by interleukin-1 and its receptor antagonist
61. Soluble interleukin-2 receptor and interleukin-2 in human amniotic fluid of normal and abnormal pregnancies
62. Increased serum concentrations of interleukin-2 receptor in the first trimester in women who later developed severe preeclampsia
63. Changes in immune activation markers during pregnancy and postpartum
64. Increased levels of cytokines and cytokine activity modifiers in normal pregnancy
65. Soluble interleukin-6 (IL-6) receptor in the sera of pregnant women forms a complex with IL-6 and augments human chorionic gonadtropin production by normal human trophoblasts through binding to the IL-6 signal transducer
66. Expression of cytokine receptors in the placenta in term and preterm labour
67. Expression of leukaemia inhibiory factor (LIF) receptor in human placenta: A possible role for LIF in the growth and differentiation of trophoblasts
68. Molecular basis of the soluble and membrane-bound forms of the murine leukemia inhibitory factor receptor alpha-chain. Expression in normal, gestating, and leukemia inhibitory factor nullizygous mice
69. Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation
70. The presence in human serum of a circulating soluble leukemia inhibitory factor recptor (sgp 190) and its evolution during pregnancy
71. Possible role of variant RNA transcripts in the regulation of epidermal growth factor receptor expression in human placenta
72. Soluble TNF receptors in amniotic fluid and in urine from pregnant women
73. Detection of soluble receptors for tumor necrosis factor, interleukin-2 and interleukin-6 in retroplacental serum from normal pregnant women
74. Shedding of tumour necrosis factor receptors from purified villous term trophoblasts and cytotrophoblastic BeWo cells
75. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation
76. Expression of mRNA for vascular endothelial growth factor transmembraneous receptors Flt1 and KDR, and the soluble receptor sflt cycling human endometrium
77. Interleukin-1 receptor antagonist is a member of the interleukin-1 gene family: Evolution of a cytokine control mechanism
78. Induction of interleukin-1 and interleukin-1 receptor antagonist
79. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptor
80. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells
81. Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy
82. Variation in detection of VEGF in maternalserum by immunoassay and the possible influence of binding proteins
83. Vascular endothelial growth factor is bound in amniotic fluid and maternal serum